🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Perpetua tests antimony for U.S. supply chain

Published 12/09/2024, 09:05 AM
PPTA
-

BOISE, Idaho - Perpetua Resources Corp. (NASDAQ: PPTA) (TSX: PPTA), a mining company with a market capitalization of $859 million that has seen its stock surge over 280% year-to-date according to InvestingPro, has announced a collaboration with U.S. Antimony Corporation (NYSE: UAMY) to conduct metallurgical testing of antimony concentrate from the Stibnite Gold Project in Idaho. This partnership aims to establish a fully domestic antimony supply chain in the United States.

Jon Cherry, President and CEO of Perpetua Resources, emphasized the company's commitment to creating a U.S. antimony supply chain to meet domestic needs. Gary C. Evans, Chairman of U.S. Antimony Corporation, echoed this sentiment, citing his company's history in processing antimony products for American users and its dedication to meeting growing domestic demand.

The Stibnite Gold Project boasts one of the largest non-Chinese antimony reserves, with 148 million pounds of antimony. In its initial six years, the project is expected to fulfill about 35% of the U.S. antimony demand, according to the 2023 USGS antimony commodity summary. InvestingPro data shows the company maintains a healthy financial position with a current ratio of 2.31, indicating strong liquidity to support project development.

Perpetua Resources is focused on the exploration and redevelopment of gold-antimony-silver deposits in central Idaho, with the Stibnite Gold Project designed to restore an abandoned mine site and produce gold and the only mined source of antimony in the U.S. The project will also support environmental restoration and is expected to be powered by a low-emission energy grid. Additionally, a portion of the produced antimony will supply Ambri, a company developing a liquid metal battery crucial for the low-carbon energy transition.

The company has received a $59.2 million Technology Investment Agreement to advance the project's construction readiness and permitting. Antimony trisulfide from the Stibnite site is identified as the only known domestic source capable of meeting U.S. defense needs for various armaments.

Investors are advised that the memorandum of understanding with U.S. Antimony is non-binding and that there is no guarantee of a definitive agreement resulting from the current arrangement. This collaboration is a step in the permitting and development process, which includes a public review period and potential adjustments by regulatory bodies. While analysts maintain a positive outlook with price targets ranging from $13.75 to $22, detailed analysis and additional insights are available through InvestingPro's comprehensive research reports, which cover over 1,400 US stocks including PPTA.

This article is based on a press release statement and provides an overview of the partnership between Perpetua Resources and U.S. Antimony Corporation aimed at forming a domestic antimony supply chain.

In other recent news, Perpetua Resources Corp. has priced its public offering of 3,439,465 common shares at $10.17 each, with an aim to generate gross proceeds of approximately $35 million. This capital is earmarked for down payments on materials, detailed engineering for the Stibnite Gold Project, and general corporate purposes. BMO Capital Markets and National Bank of Canada (OTC:NTIOF) Financial Markets are acting as joint lead book-running managers for the offering.

The Stibnite Gold Project, a high-grade open-pit gold deposit in the United States, is a key focus for Perpetua Resources. The project is expected to supply antimony, a critical mineral for defense and technology applications, to Ambri, a company specializing in liquid metal batteries. The company has secured a $59.2 million Technology Investment Agreement for the project under the Defense Production Act.

Perpetua Resources' financial developments include a decrease in net loss to $2.9 million in Q1 2024, largely due to an increase in grant income to $5.2 million. The company has enlisted RBC Capital Markets and Endeavour Financial to explore strategic and financing opportunities.

In analyst news, H.C. Wainwright has raised the stock's price target to $22.00, Roth/MKM has increased the price target from $10.00 to $12.00, and Cantor Fitzgerald has upgraded the stock's rating to Buy from the previous Speculative Buy, setting a new price target at Cdn$18.25. These upgrades reflect the company's ongoing progress on the Stibnite Gold Project and the strategic importance of domestic antimony production.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.